The Interdependence of Allergic and Inflammatory Processes

  • Lawrence M. Lichtenstein

Abstract

In a widely accepted system of classification, allergic reactions have been divided by Gell and Coombs into four different categories (1). Their definition of allergy is the classical one, rather than the limited modern or clinical definition, and, therefore, purports to encompass the totality of reactions which involve the immune system. While this classification has served a useful role, it will be the purpose of this discussion to review recent data which suggests that allergic reactions are an integral part of the whole range of inflammatory responses, and, perhaps, should no longer be divided in this fashion. It will be suggested, instead, that these responses, which are of major importance in both defense mechanisms and in disease processes, have a pathogenesis in which each of the traditional types of allergic response are so inextricably intermingled that they are best considered as constituting a continuum.

Keywords

Histamine Prostaglandin Theophylline Rhinitis Nephritis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gell, P.G.H. and Coombs, R.R.A. Clinical aspects of immunology. 2nd Edit. F.A. Davis, Phil., Pa. 1968 (p. 575).Google Scholar
  2. 2.
    Lichtenstein, L.M. and Osier, A.G. Studies on the mechanisms of hypersensitivity phenomena. IX. Histamine release from human leukocytes by ragweed pollen antigen. J. Exp. Med., 120: 507, 1964.PubMedCrossRefGoogle Scholar
  3. 3.
    Ishizaka, T., DeBernardo, R., Tomioka, Hisao, Lichtenstein, L.M. and Ishizaka, K. Identification of basophil granulocytes as a site of allergic histamine release. J. Immun., 108: 1000, 1972.PubMedGoogle Scholar
  4. 4.
    Grant, J.A. and Lichtenstein, L.M. Release of slow reacting substance of anaphylaxis from human leukocytes. J. Immun., 112: 897, 1974.PubMedGoogle Scholar
  5. 5.
    Lewis, R.A., Goetzl, E.J., Wasserman, S.I., Valone, F.H., Rubin, R.H. and Austen, K.F. The release of four mediators of immediate hypersensitivity from human leukemic basophils. J. Immunol. 114: 87, 1975.PubMedGoogle Scholar
  6. Czarnetzki, B.M., Konig, W. and Lichtenstein, L.M. Antigeninduced eosinophil chemotactic factor (ECF) release by human leukocytes. Inflammation, In Press.Google Scholar
  7. 7.
    Newball, H.H., Talamo, R.C., and Lichtenstein, L.M. Release of leukocyte kallikrein mediated by IgE. Nature 254: 635, 1975.PubMedCrossRefGoogle Scholar
  8. 8.
    Lichtenstein, L.M. and Margolis, S. Histamine release in vitro: Inhibition by catecholamines and methylxanthines. Science, 161: 902, 1968.PubMedCrossRefGoogle Scholar
  9. 9.
    Bourne, H.R., Lichtenstein, L.M. and Melmon, K.L. Pharmacologic control of allergic histamine release in vitro: Evidence for an inhibitory role of 3’,5’-adenosine monophosphate in human leukocytes. J. Immun., 108: 695, 1972.PubMedGoogle Scholar
  10. 10.
    Kaliner, M. and Austen, K.F. Cyclic AMP, ATP and reversed anaphylactic histamine release from rat mast cells. J. Immunol. 112: 664, 1974.PubMedGoogle Scholar
  11. 11.
    Gillespie, E. Compound 48/80 decreases adenosine 3’,5’-mono- phosphate formation in rat peritoneal mast cells. Experientia 29: 447, 1973.PubMedCrossRefGoogle Scholar
  12. 12.
    Ishizaka, T., Ishizaka, K., Orange, R.P. and Austen, K.F. Pharmacologic inhibition of the antigen-induced release of histamine and slow-reacting substance of anaphylaxis (SRS-A) from monkey lung tissues mediated by human I. J. Immunol. 106: 1267, 1971.PubMedGoogle Scholar
  13. 13.
    Orange, R.P., Austen, W.G. and Austen, K.F. Immunologic release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3’5’-adenosine monophosphate. J. Exp. Med.134: 1365, 1971.Google Scholar
  14. 14.
    Kaliner, M., Orange, R.P. and Austen, K.F. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. IV. Enhancement by cholinergic and alpha adrenergic stimulation. J. Exp. Med. 136: 556, 1972.PubMedCrossRefGoogle Scholar
  15. 15.
    Zurier, R.B., Weissmann, G., Hoffstein, S., Kammerman, S. and Tai, H.H. Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of MP and MP, autonomic agonists, and agents which affect microtubule function. J. Clin. Invest. 53: 297, 1974.PubMedCrossRefGoogle Scholar
  16. 16.
    Henson, P.M. Mechanisms of activation and secretion by platelets and neutrophils. Prog. Immunol. II. 2: 95, 1974.Google Scholar
  17. 17.
    Henney, C.S., Bourne, H.R. and Lichtenstein, L.M. The role of cyclic 3’,5’-adenoslne monophosphate in the specific cytolytic activity of lymphocytes. J. Immun., 108: 1526, 1972.PubMedGoogle Scholar
  18. 18.
    Lichtenstein, L.M., Henney, C.S., Bourne, H.R. and Greenough, W.B. Effects of cholera toxin on in vitro models of immediate and delayed hypersensitivity: Further evidence for the role of MP. J. Clin. Invest. 52: 691, 1973.PubMedCrossRefGoogle Scholar
  19. 19.
    Colman, R.W. Formation of human plasma kinin. N. Engl. J. Med. 291: 509, 1974.PubMedCrossRefGoogle Scholar
  20. 20.
    Cochrane, C.G., Revak, S.D., Aikin, B.S. and Wuepper, K.D. The structural characteristics and activation of Hageman factor. In Inflammation: Mechanisms and Control. I.H. Lepow and P.A. Ward, editors. Academic Press, New York. 1972. pp. 119–138.Google Scholar
  21. 21.
    Prado, J.L. Proteolytic enzymes as kininogenases. In Handbook of Exper. Pharmacol. E.G. Erdos, editor. Springer- Verlag, New York. 25: 156, 1970.Google Scholar
  22. 22.
    Orange, R.P. The formation and release of slow reacting substance of anaphylaxis in human lung tissues. Prog. Immunol. II. 4: 29, 1974.Google Scholar
  23. 23.
    Talamo, R.C., Haber, E. and Austen, K.F. A radioimmunoassay for bradykinin in plasma and synovial fluid. J. Lab. Clin. Med. 74: 816, 1969.PubMedGoogle Scholar
  24. 24.
    Halonen, M. and Pinckard, R.N. Intravascular effects of IgE antibody upon basophils, neutrophils, platelets and blood coagulation in the rabbit. J. Immunol. 115: 519, 1975.PubMedGoogle Scholar
  25. 25.
    Bourne, H.R., Melmon, K.L. and Lichtenstein, L.M. Histamine augments leukocyte cyclic AMP and blocks antigenic histamine release. Science, 173: 743, 1971.PubMedCrossRefGoogle Scholar
  26. 26.
    Black, J.W., Duncan, W.A.M., Durant, C.J., Ganellin, C.R. and Parsons, E.M. Definition and antagonism of histamine H2- receptors. Nature 236: 385, 1972.PubMedCrossRefGoogle Scholar
  27. 27.
    Lichtenstein, L.M. and Gillespie, E. The effects of the HI and H2 antihistamines on “allergic” histamine release and its inhibition by histamine. J. Pharm. Exp. Therap. 192: 441, 1975.Google Scholar
  28. 28.
    Plaut, M., Lichtenstein, L.M. and Henney, C. Increase in histamine receptors on thymus-derived effector lymphocytes during the primary immune response to alloantigens. Nature 244: 284, 1973.PubMedCrossRefGoogle Scholar
  29. 29.
    Plaut, M., Lichtenstein, L.M. and Henney, C.S. Properties of a subpopulation of T cells bearing histamine receptors. J. Clin. Invest. 55: 856, 1975.PubMedCrossRefGoogle Scholar
  30. 30.
    Makman, M.H. Properties of adenyl cyclase of lymphoid cells. Proc. Nat. Acad. Sci. USA 68: 885, 1971.Google Scholar
  31. 31.
    Weinstein, Y., Melmon, K.L., Bourne, H.R. and Sela, M. Specific leukocyte receptors for small exogenous hormones. Detection by cell binding to insolubilized hormone preparations. J. Clin. Invest. 52: 1349, 1973.PubMedCrossRefGoogle Scholar
  32. 32.
    Hill, H.R., Estenson, R.D., Quie, P.G., Hogan, N.A. and Goldberg, N.D. Modulation of human neutrophil chemotactic responses by cyclic 3’,5’-guanosine monophosphate and cyclic 3’,5’-adenosine monophosphate. Metabolism 24 447, 1975.PubMedCrossRefGoogle Scholar
  33. Rocklin, R.E. Modulation of cellular immune response in vitro and in vivo by histamine. J. Clin. Invest., in press.Google Scholar
  34. 34.
    Chakrin, L.W., Krell, R.D., Mengel, J. et al. Effect of a histamine H-2 receptor antagonist in immunologically induced mediator release in vitro. Agents and Actions 4: 297, 1974.PubMedCrossRefGoogle Scholar
  35. 35.
    Kravis, T.C. and Zvaifler, N.J. Alteration of rabbit PCA reaction by drugs known to influence intracellular cyclic AMP. J. Immunol. 113: 244, 1974.PubMedGoogle Scholar
  36. 36.
    Zurier, R.B. and Sayadoff, D.M. Release of prostaglandins from human polymorphonuclear leukocytes. Inflammation. 1: 93, 1975.CrossRefGoogle Scholar
  37. 37.
    Barrett-Bee, K.J. and Green, L.R. The relationship between prostaglandin release and lung c-AMP levels during anaphylaxis in the guinea pig. Prostaglandins 10: 589, 1975.PubMedCrossRefGoogle Scholar
  38. 38.
    Lichtenstein, L.M., Gillespie, E., Bourne, H.R. and Henney, C.S. The effects of a series of prostaglandins on in vitro models of the allergic response and cellular immunity. Prostaglandins 2: 519, 1972.PubMedCrossRefGoogle Scholar
  39. 39.
    Hamberg, M., Svensson, J. and Samuelsson, B. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. 72: 2994, 1975.PubMedCrossRefGoogle Scholar
  40. 40.
    Lichtenstein, L.M. The mechanism of basophil histamine release induced by antigen and by the calcium ionophore A23187. J. Immunol. 114: 1692, 1975.PubMedGoogle Scholar
  41. Conroy, M.C., Orange, R.P. and Lichtenstein, L.M. Slow reacting substance (SRS-A) release from human granulocytes by the calcium ionophore A23187. J. Immunol., in press.Google Scholar
  42. 42.
    Orange, R.P., Murphy, R.C., Karnovsky, M.L. and Austen, K.F. The physicochemical characteristics and purification of slow reacting substance of anaphylaxis. J. Immunol. 110: 760, 1973.PubMedGoogle Scholar
  43. 43.
    Orange, R.P., Valentine, M.D. and Austen, K.F. Antigen induced release of slow reacting substance of anaphylaxis (SRS-Arat) in rats prepared with homologous antibody. J. Exp. Med. 127: 767, 1968.PubMedCrossRefGoogle Scholar
  44. 44.
    Kay, A.B. and Austen, K.F. The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. J. Immunol. 107: 899, 1971.PubMedGoogle Scholar
  45. 45.
    Wasserman, S.I., Goetzl, G.J. and Austen, K.F. Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase. J. Immunol. 114: 645, 1975.PubMedGoogle Scholar
  46. Zeiger, R.S., Yurdin, B.A. and Colten, H.R. Histamine catabolism: Localization of histaminase and histamine methyl transferase in human leukocytes. J. Allergy Clin. Immunol., in press.Google Scholar
  47. Czarnetzki, B.M., Konig, W. and Lichtenstein, L.M. Eosinophil chemotactic factor (ECF) I: Release from polymorphonuclear leukocytes by the calcium ionophore A23187. J. Immunol., in press.Google Scholar
  48. Konig, W., Czarnetzki, B.M. and Lichtenstein, L.M. Eosinophil chemotactic factor (ECF) II: Release during phagocytosis of human polymorphonuclear leukocytes. J. Immunol., in press.Google Scholar
  49. 49.
    Richerson, H.B., Dvorak, H.B. and Leskowitz, S. Cutaneous basophil hypersensitivity I. A new look at The Jones Mote Reaction, general characteristics. J. Exp. Med. 132: 546, 1970.PubMedCrossRefGoogle Scholar
  50. 50.
    Dolovitch, J., Hargreave, F.E., Chalmers, R., Shier, K.J., Gouldie, J. and Bienenstock, J. Late cutaneous allergic responses in isolated I dependent reactions. J. Allergy Clin. Immunol. 52: 38, 1973.CrossRefGoogle Scholar
  51. 51.
    Solley, G.O., Larson, J.B., Jordon, R.E. and Gleich, G.J. Late cutaneous reactions due to IgE. J. Allergy Clin. Immunol. 55: 112, 1975.Google Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • Lawrence M. Lichtenstein
    • 1
  1. 1.The Johns Hopkins University School of Medicine at the Good Samaritan HospitalBaltimoreUSA

Personalised recommendations